Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
NeuBase Therapeutics (NBSE) Q3 2023 Earnings
NBSE
19
Dec
Expected
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-2.1
-1.44
-0.77
-0.11
Details
Expected EPS
-2.1
Actual EPS
N/A
Surprise EPS
2.1
Surprise Percent
+100%
Description
NeuBase Therapeutics (NBSE) will report earnings of for Q3 2023 on December 19, 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login